Sunglasses: Your Prescription for Eye Health
Sunglasses: Your Prescription for Eye Health

Next time you step outside to enjoy the summer sun, don't forget to bring a pair of sunglasses. Most people know that the sun's damaging ultraviolet rays are bad for the skin. But did you know that too much sun on...

U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application...

Cerapedics Announces Closing of $22 Million Financing
Cerapedics Announces Closing of $22 Million Financing

Cerapedics, a privately-held orthobiologics company, today announced that the company completed a $22 million financing led by KCK Group, a family investment fund that focuses on innovative medical technologies that meet...

Surgical Instrument Tracking Systems 2018: Worldwide Market Outlook to 2024 - Rising Number of Surgeries Across the Globe is Driving Growth
Surgical Instrument Tracking Systems 2018: Worldwide Market Outlook to 2024 - Rising Number of Surgeries Across the Globe is Driving Growth

The "Global Surgical Instrument Tracking Systems Market - Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. Global surgical instrument tracking...

The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma

Array BioPharma Inc. (NASDAQ: ARRY) today announced that the National Comprehensive Cancer Network (NCCN) has updated the Clinical Practice Guidelines in Oncology for Melanoma to include BRAFTOVI™ in combination with...

TempTraq Vies to Become the New Standard-of-Care for Monitoring Patient Body Temperature in Hospitals
TempTraq Vies to Become the New Standard-of-Care for Monitoring Patient Body Temperature in Hospitals

A study presented at the 2018 Society of Critical Care Medicine conference has shown that TempTraq®, a patented, wearable, Bluetooth® continuous body temperature monitor, is in agreement with Pulmonary Artery Catheters...

Surgical Instrument Tracking Systems 2018: Worldwide Market Outlook to 2024 - Rising Number of Surgeries Across the Globe is Driving Growth
Surgical Instrument Tracking Systems 2018: Worldwide Market Outlook to 2024 - Rising Number of Surgeries Across the Globe is Driving Growth

The "Global Surgical Instrument Tracking Systems Market - Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. Global surgical instrument tracking...

The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma

Array BioPharma Inc. (NASDAQ: ARRY) today announced that the National Comprehensive Cancer Network (NCCN) has updated the Clinical Practice Guidelines in Oncology for Melanoma to include BRAFTOVI™ in combination with...

TempTraq Vies to Become the New Standard-of-Care for Monitoring Patient Body Temperature in Hospitals
TempTraq Vies to Become the New Standard-of-Care for Monitoring Patient Body Temperature in Hospitals

A study presented at the 2018 Society of Critical Care Medicine conference has shown that TempTraq®, a patented, wearable, Bluetooth® continuous body temperature monitor, is in agreement with Pulmonary Artery Catheters...

Myovant Sciences Ltd. Announces Pricing of $75.0 Million Public Offering of Common Shares
Myovant Sciences Ltd. Announces Pricing of $75.0 Million Public Offering of Common Shares

Myovant Sciences Ltd. (NYSE: MYOV) ("Myovant"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of women's health and endocrine diseases today...

Insulin Pumps (External) Markets through 2015-2022: Global Strategic Business Report 2018 - Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
Insulin Pumps (External) Markets through 2015-2022: Global Strategic Business Report 2018 - Expiry of Warranty Provides New Opportunities to Insulin Pump Makers

The "Insulin Pumps (External) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Europe,...

MemorialCare Long Beach Selects Vizzia Technologies for Emergency Department (ED) Patient Workflow Solution
MemorialCare Long Beach Selects Vizzia Technologies for Emergency Department (ED) Patient Workflow Solution

Vizzia Technologies, a leading provider of managed real-time location systems (RTLS) for healthcare organizations, announced that MemorialCare Health System has selected Vizzia and its RTLS partner Sonitor, to deploy a...

Seniors Overwhelmingly Support Pharmacy-Related Part D Reforms, Survey Says
Seniors Overwhelmingly Support Pharmacy-Related Part D Reforms, Survey Says

Reducing drug costs borne by seniors due to middlemen and deals in the drug supply chain are Medicare Part D reforms that most strongly curry favor among registered voters, according to a Morning Consult survey...

Global Special Purpose Needles Industry
Global Special Purpose Needles Industry

This report analyzes the worldwide markets for Special Purpose Needles in US$ Thousand by the following Product Segments: Aspirating Needles, Biopsy Needles, Blood Collection Needles, IV/Catheter Needles, Dental Needles,...

Global Benign Prostatic Hyperplasia Therapeutics Market Expected to Reach $20,097 Million by 2025 | Allied Market Research
Global Benign Prostatic Hyperplasia Therapeutics Market Expected to Reach $20,097 Million by 2025 | Allied Market Research

According to a new report published by Allied Market Research, titled, "Benign Prostatic Hyperplasia Therapeutics Market, by Therapeutics Class and Therapy: Global Opportunity Analysis and Industry Forecast, 2018-2025,"...

Global Medical Spa Market Expected to Reach $27,566 Million by 2025, Says Allied Market Research
Global Medical Spa Market Expected to Reach $27,566 Million by 2025, Says Allied Market Research

According to a new report published by Allied Market Research, titled, "Medical Spa Market by Service: Global Opportunity Analysis and Industry Forecast, 2017-2025," the global medical spa market was valued at $11,063...

Global ADME-Toxicology Testing Industry
Global ADME-Toxicology Testing Industry

This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ by the following Segments: Toxicology Testing (In-Vivo, In-Vitro), and ADME Testing. Read the full report:...

Health Canada Approves Tagrisso® (osimertinib) as First-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer
Health Canada Approves Tagrisso® (osimertinib) as First-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer

Pivotal FLAURA study demonstrated 18.9 months median progression-free survival  for patients receiving Tagrisso versus 10.2 months compared with earlier generation EGFR tyrosine kinase inhibitors

Blue Cross and Blue Shield Companies Make Landmark Decision to Advance Better Treatment Options for Opioid Use Disorder
Blue Cross and Blue Shield Companies Make Landmark Decision to Advance Better Treatment Options for Opioid Use Disorder

Almost a quarter of a million Blue Cross and Blue Shield (BCBS) members were diagnosed with opioid use disorder in 2017. To find reliable support for these members – and all Americans suffering from opioid use disorder –...

BD Shares Progress towards Achieving 2020 Sustainability Goals
BD Shares Progress towards Achieving 2020 Sustainability Goals

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company's...

OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications
OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications

OrigiMed announces an agreement with Illumina in Shanghai, China. It will develop and promote its advanced molecular clinical tumor applications to the public based on the Next Generation Sequencing (NGS) technology of...

Connect 

Dr. Muhammad Mirza Helps Clients Escape Chronic Migraine Pain Through Botox
Dr. Muhammad Mirza Helps Clients Escape Chronic Migraine Pain Through Botox

Chronic migraines affect 36 million Americans. Migraines are more than a simple headache; they are consistent and debilitating. In fact, a study in 2016 found that migraines ranked second as being the most debilitating...

Diabetes Research Institute Launches New Clinical Trial to Explore Effects of Omega-3 Fatty Acids and Vitamin D in Type 1 Diabetes
Diabetes Research Institute Launches New Clinical Trial to Explore Effects of Omega-3 Fatty Acids and Vitamin D in Type 1 Diabetes

Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine today announced the launch of a new clinical trial that will assess the impact of high-dose omega-3 fatty acids and...

Genomma Lab Internacional S.A.B. DE C.V. Second Quarter 2018 Results Conference Call
Genomma Lab Internacional S.A.B. DE C.V. Second Quarter 2018 Results Conference Call

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Genomma Lab Internacional, S.A.B de C.V. MEXICO CITY, July 11, 2018 /PRNewswire/ -- Presenters: Mr. Máximo Juda, Chief Executive Officer Mr. Antonio Zamora, Chief Financial Officer Mr. Enr...

Aurigene Announces First in Human Dosing with RoR?t Inverse Agonist AUR-101
Aurigene Announces First in Human Dosing with RoR?t Inverse Agonist AUR-101

Aurigene, a biotechnology company focused on discovering and developing drugs for oncology and inflammatory disorders, announced today that it has commenced dosing in INDUS, a Phase 1 trial of AUR-101 in healthy...

CVS Health Corporation Announces Quarterly Dividend
CVS Health Corporation Announces Quarterly Dividend

CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation's common stock. The dividend is payable on August 1,...

Global Pulse Oximeters Industry
Global Pulse Oximeters Industry

This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousand by the following Product Segments and Point-of-Care markets: Product Segments -Handheld Pulse Oximeters, Finger Pulse Oximeters, and Others;...

Global Pipettes and Pipettors Industry
Global Pipettes and Pipettors Industry

This report analyzes the worldwide markets for Pipettes and Pipettors in Units and US$ by the following Product Segments: Electronic Pipettors, Mechanical Pipettors, Glass Pipettes, Plastic Pipettes, and Pipette Tips. ...

Global Medical Imaging Equipment Services Industry
Global Medical Imaging Equipment Services Industry

This report analyzes the worldwide markets for Medical Imaging Equipment Services in US$ by the following Segments: OEM, and Other Service Providers. Read the full report: https://www.reportlinker.com/p098273 The report...

Global Pediatric Drugs and Vaccines Industry
Global Pediatric Drugs and Vaccines Industry

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs,...

Global Market Study on Prepackaged Medical Kits and Trays: Robust Demand for Disposable Products from Multi-specialty Hospitals Fuel Sales
Global Market Study on Prepackaged Medical Kits and Trays: Robust Demand for Disposable Products from Multi-specialty Hospitals Fuel Sales

Research Methodology PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market...

IVF Devices and Consumables Market Worth $6,891 Million by 2025, at a CAGR 17.6%: Allied Market Research
IVF Devices and Consumables Market Worth $6,891 Million by 2025, at a CAGR 17.6%: Allied Market Research

According to a new report published by Allied Market Research, titled, "IVF Devices and Consumables Market, by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025," the...

Global Laparoscopic Devices Industry
Global Laparoscopic Devices Industry

This report analyzes the worldwide markets for Laparoscopic Devices in US$ Thousand by the following Product Segments: Laparoscopes, Trocars,  Insufflation and Suction/Irrigation Devices, Closure Devices, Hand Instruments,...

Global Disposable Medical Gloves Industry
Global Disposable Medical Gloves Industry

This report analyzes the worldwide markets for Disposable Medical Gloves in US$ by the following Product Segments: Examination Gloves, and Surgical Gloves. Download the full report:...

BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia

BioSight Ltd., a pharmaceutical development company focused on the development of targeted oncology drugs, announced today that it has received the FDA and the Israeli Ministry of Health clearance to launch a Phase 2b...

Global CNS Therapeutics Industry
Global CNS Therapeutics Industry

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimers, Anti-Parkinsons, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants, and...

US News 

Local News 

World News